Influenza-like Illness Clinical Trial
Official title:
An Observational Study to Characterize Children and Adults With Influenza Like Illness (ILI) in Mexico
A study to characterize children and adults with influenza like symptoms and to determine risk factors for severe disease and death among those with H1N1.
In March 2009, a new influenza A virus, novel H1N1 (commonly referred to as "swine flu"),
began causing an increase in reports of influenza-like illness in North America. Although
the virus subsequently spread rapidly around the world, the earliest reported outbreak of
cases occurred in Mexico City, which is seen as the epicenter of the influenza pandemic, the
world's first in 40 years.
Many questions remain about this emerging pandemic and the virus causing it, the answers to
which could better inform patient management and policy decisions both in Mexico and
internationally. Sparse reliable clinical research data have been collected on the natural
history of the disease, on the risk factors associated with severe disease, or on the
severity of this pandemic influenza as compared to seasonal influenzas. This study is an
initial step to better characterize individuals in Mexico who develop influenza-like illness
(including illness caused by novel H1N1), to describe the clinical management of those
individuals, and to assess their short-term outcome. The planned data collection will
provide timely information to inform policy and guidelines for the local populations and
governments involved and may also be used to design future ancillary studies of this
influenza virus and/or studies of other emerging infectious diseases.
The purpose of this observational study is to characterize individuals in Mexico who seek
medical care for influenza-like illness (ILI) and to describe clinical course over a period
of at least 28 days after enrollment.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02302924 -
Evaluation of Psychometric Testing Properties of Severity Symptom Grading Scale of Influenza Infection: Flu-PRO Stage III
|
||
Completed |
NCT00981513 -
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households
|
Phase 4 | |
Completed |
NCT03274310 -
FluSAFE: Flu SMS Alerts to Freeze Exposure
|
N/A | |
Completed |
NCT03695432 -
Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly
|
Phase 4 | |
Active, not recruiting |
NCT03734237 -
A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD
|
Phase 4 | |
Completed |
NCT04646980 -
Biobran/MGN-3 Increases Innate Resistance and Reduces the Incidence of Influenza-like Illnesses
|
N/A | |
Completed |
NCT03599739 -
Adjuvanted Influenza Vaccination Year 2 Follow-On Survey
|
||
Completed |
NCT02979730 -
Impact of Rapid Flu Testing in BMC ED
|
N/A | |
Completed |
NCT03454009 -
Kent State University / Price Chopper Employee Wellness Study
|
N/A | |
Active, not recruiting |
NCT01687816 -
Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient Setting
|
N/A | |
Completed |
NCT00448773 -
REDucing Influenza Among University Students, University of California at Berkeley
|
Phase 4 | |
Completed |
NCT03656198 -
Non-specific Effects of Rabies Vaccine
|
Phase 4 | |
Completed |
NCT02882100 -
Adjuvanted Influenza Vaccination in U.S. Nursing Homes
|
Phase 4 |